Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in FocusZacks.comOur experts cut down 220 Zacks Rank #1 Strong Buys to the 7 that are most likely to jump in price immediately. For 28 years, the full Strong Buy list has averaged a stellar +25% per year… Continue reading
Immuno-Oncology News |
Kite and Sagamo Are Partnering on Cell-engineered Treatments for Cancer
Immuno-Oncology News While this kind of immunotherapy can treat only one kind of cancer, the partners hope to develop specific treatments for several types. The therapies modify either a patient’s own cells or cells that others donate. The companies hope the donated … |
The Ohio State University News |
Newly discovered CRISPR mechanism may help prevent dangerous errors
The Ohio State University News COLUMBUS, Ohio—Even as CRISPR gene-editing technology is offering insights into genetic diseases, researchers are discovering new things about how it actually works. In the first of two papers just published in the Journal of the American Chemical … Could A More Precise CRISPR/Cas9 System Treat Huntington’s Disease?Labiotech.eu (blog) Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation ApplicationsBusiness Wire (press release) |
|
How A Bank Of All The World’s Genetic Codes Hopes To Save Nature
Fast Company Without their cooperation in putting the biological data into the registry, it will be difficult for the project to move forward successfully. “We’ll probably have to create a consortium such that they’re acting in the public interests appropriate to … |
FierceBiotech |
Inscripta bags $55M+ to push forward full CRISPR suite
FierceBiotech Inscripta bags $55M+ to push forward full CRISPR suite. by Amirah Al Idrus |. Feb 28, 2018 6:00am. CRISPR. Inscripta’s goal is to enable more players, be they startups or major companies, to enter the CRISPR space. (Stephen Dixon). ShareFacebook … Gene-editing startup Inscripta raises $55.5 millionBusiness Insider Boulder’s Inscripta raises $55.5MBoulder Daily Camera |
Business Wire (press release) |
Could A More Precise CRISPR/Cas9 System Treat Huntington’s Disease?
Labiotech.eu (blog) Polish researchers tested a new variant of CRISPR/Cas9 that increases the gene-editing system’s precision in targeting specific DNA sequences, such as the gene responsible for Huntington’s disease. CRISPR/Cas9 offers a means of editing genes by … Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation ApplicationsBusiness Wire (press release) Newly discovered CRISPR mechanism may prevent dangerous errorsPhys.Org |